CMC Drug Development connects Chemistry, Manufacturing and Controls expectations, phase-graded regulatory requirements, and program timelines for Small Molecule, Cell Therapy, and Gene Therapy into one structured navigation system.
Know the requirements. Plan the timeline. Navigate the gate. File with confidence.
The Common CMC Problem
CMC Drug Development replaces reactive discovery of regulatory expectations with a structured, phase-graded navigation system — mapped to CTD sections, modality, dosage form, and development stage before the work begins.
Studies, methods, and packages that should have been scoped at IND appear as surprises at Phase 2 or Phase 3.
Missing or incomplete CTD sections discovered during submission assembly push NDA or BLA timelines by months.
CMC deficiency letters require costly response cycles, additional studies, and extended review timelines.
Every CMC gap that surfaces late translates directly into delayed product availability for the patients who need it.
Three Integrated Tools
CMC Drug Development gives development teams, CMC leads, and regulatory professionals a connected navigation system that spans the full lifecycle — from early molecule selection through commercial readiness.
Navigate all 77 CTD Module 3 sections with phase expectations (IND → Phase 2 → Phase 3 → NDA/BLA), regulatory watchouts, and ICH/FDA/EMA reference citations — filtered to your molecule and dosage form.
Modality-specific timelines showing your target vs. industry average at every phase — so you know exactly where structured CMC planning compresses the calendar.
From Opportunity/Portfolio (G0) through Lifecycle (G10) — each gate defines the decision question, core evidence required, Go/Conditional-Go/No-Go framework, and required signatories. Internal SME readiness assessment → gate review → decision → formal sign-off.
Three Modalities. One Platform.
Small molecule, cell therapy, and gene therapy development paths are structurally different. CMC Drug Development treats them that way.
From target identification through NDA approval. Pre-formulation, formulation development, PK/PD, full ICH toxicology, GMP DS/DP manufacturing, and clinical development. 572 cross-mapped tasks.
Construct selection, cell collection & donor eligibility, cell processing, analytical method development, GMP manufacturing, IND through BLA — with modality-specific CMC expectations for living cell products.
Target strategy, modality decision gate, lead vector selection, production process, GLP biodistribution, GMP vector manufacturing, IND through BLA — with gene therapy-specific CMC expectations.
Request Your Program Plan
Provide your program details below and we will return a modality-specific stage-gate schedule and gate checklist tailored to your development pathway.
All fields help us return the most relevant program plan for your development stage and molecule type.
We will send your program plan to the email provided within 1–2 business days.
Part of the I²nnovate Ecosystem
Aligned Strategy · Actionable Insights · Disciplined Execution · Measurable Results
Aligns strategy, people, process, systems, performance, and leadership cadence into one system for sustainable high performance.
i2nnovate.com →Integrated KPI dashboards that convert data into clarity, decisions, ownership, and action across the organization.
theactionableinsights.com →Program and governance framework that prioritizes, manages, and delivers initiatives for measurable and sustainable business results.
pmoperformance.com →Phase-graded CMC requirements, modality-specific program timelines, and stage-gate frameworks — from IND through approval across Small Molecule, Cell Therapy, and Gene Therapy.
Stage-gated CDMO management platform with PSQDC scorecards and weighted performance index for sponsor-side oversight of external manufacturing partnerships.
cdmoperformance.com →Ready to Navigate CMC?
Start with the CMC Navigator to explore phase-graded requirements for your CTD sections, explore the development timelines for your modality, or request your modality-specific program plan and gate checklist.